Lavarino, Cinzia
Hospital Sant Joan de Déu Barcelona · Institut de Recerca Sant Joan de Déu
3 papers on CoChatORCID 0000-0002-9630-3676
Most cited papers
- Verified
EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas
Mohammad, F., Weissmann, S., Leblanc, B., Pandey, D. P., Højfeldt, J. W., Comet, I., Zheng, C., Johansen, J. V., Rapin, N., Porse, B. T., et al. (2017) · Nature Medicine
Glioma Diagnosis and TreatmentChromatin Remodeling and Cancer
Cited by 535
- Verified
Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma
Perry, J. A., Kiezun, A., Tonzi, P., Van Allen, E. M., Carter, S. L., Baca, S. C., Cowley, G. S., Bhatt, A. S., Rheinbay, E., Pedamallu, C. S., et al. (2014) · Proceedings of the National Academy of Sciences
Sarcoma Diagnosis and TreatmentPI3K/AKT/mTOR signaling in cancer
Cited by 481
- Verified
Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01
Pascual-Pasto, G., Bazan-Peregrino, M., Olaciregui, N. G., Restrepo-Perdomo, C. A., Mato-Berciano, A., Ottaviani, D., Weber, K., Correa, G., Paco, S., Vila-Ubach, M., et al. (2019) · Science Translational Medicine
Virus-based gene therapy researchOcular Oncology and Treatments
Cited by 118
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free